{
  "trial_id": "NCT03452033",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, baseline intraocular pressure (IOP), best-corrected visual acuity (BCVA), history of ocular hypotensive medication use, history of ocular surgeries, corneal thickness, presence of pigment dispersion syndrome/glaucoma, history of ocular conditions (e.g., uveitis, keratitis, scleritis), history of systemic diseases (e.g., diabetes, hypertension), use of systemic medications affecting IOP, history of drug or alcohol abuse, pregnancy status, history of participation in other clinical studies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Intraocular pressure",
          "baseline intraocular pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "best-corrected visual acuity (BCVA)",
        "history of ocular hypotensive medication use",
        "history of ocular surgeries",
        "corneal thickness",
        "presence of pigment dispersion syndrome/glaucoma",
        "history of ocular conditions (e.g., uveitis, keratitis, scleritis)",
        "history of systemic diseases (e.g., diabetes, hypertension)",
        "use of systemic medications affecting IOP",
        "history of drug or alcohol abuse",
        "pregnancy status",
        "history of participation in other clinical studies."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Intraocular Pressure (IOP), Best-corrected visual acuity (BCVA), Corneal thickness, History of ocular surgery, History of ocular conditions, Use of ocular hypotensive medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Intraocular pressure",
          "Baseline Intraocular Pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Best-corrected visual acuity (BCVA)",
        "Corneal thickness",
        "History of ocular surgery",
        "History of ocular conditions",
        "Use of ocular hypotensive medications"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Best-Corrected Visual Acuity, Intraocular Pressure, Central Corneal Thickness, Cup-to-Disc Ratio, Visual Field Mean Deviation, Diabetic Retinopathy Status, History of Glaucoma Surgery, History of Ocular Hypotensive Medication Use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Intraocular pressure",
          "Intraocular Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Best-Corrected Visual Acuity",
        "Central Corneal Thickness",
        "Cup-to-Disc Ratio",
        "Visual Field Mean Deviation",
        "Diabetic Retinopathy Status",
        "History of Glaucoma Surgery",
        "History of Ocular Hypotensive Medication Use."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, best-corrected visual acuity (BCVA), intraocular pressure (IOP), corneal thickness, cup-to-disc ratio, visual field mean deviation, spherical equivalent refraction, axial length, diagnosis of primary open angle glaucoma or ocular hypertension, use of ocular hypotensive medication(s), medical history (e.g., diabetes, hypertension), concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Intraocular pressure",
          "intraocular pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "best-corrected visual acuity (BCVA)",
        "corneal thickness",
        "cup-to-disc ratio",
        "visual field mean deviation",
        "spherical equivalent refraction",
        "axial length",
        "diagnosis of primary open angle glaucoma or ocular hypertension",
        "use of ocular hypotensive medication(s)",
        "medical history (e.g., diabetes, hypertension)",
        "concomitant medications"
      ]
    }
  }
}